<DOC>
	<DOCNO>NCT01697826</DOCNO>
	<brief_summary>Randomized , Parallel Group , Active Controlled Trial compare effectiveness tolerability 2 different vaginal formulation contain 200mg clotrimazole clindamycin phosphate equivalent 100mg clindamycin 3 day woman clinically diagnose infective vaginitis .</brief_summary>
	<brief_title>Comparison Two Topical Formulations Containing Clindamycin Clotrimazole Patients With Vaginal Infections</brief_title>
	<detailed_description>- This Randomized , Comparative , Prospective , Open label , Single center study compare 3 day treatment course intravaginal soft gelatin capsule contain clindamycin clotrimazole versus intravaginal ER tablet clindamycin clotrimazole patient vaginal discharge clinical diagnosis bacterial , trichomonal , candidal mixed vaginitis respect efficacy tolerability ; study vitro drug release pattern intravaginal soft gelatin capsule intravaginal ER tablet contain clindamycin clotrimazole . - The study conduct B.J . Medical College &amp; Sassoon General Hospitals , Pune . The study complete 60 patient [ 30 patient group ] . - The primary outcome measure absence clinical sign suggestive infective vaginitis vaginal swab negative bacterial , trichomonal candidal vaginitis 8th day start treatment [ Effectiveness induce remission ] . - The secondary outcome measure 1. absence clinical sign suggestive infective vaginitis 2. vaginal swab negative bacterial , trichomonal candidal vaginitis 29th day start treatment [ Effectiveness maintain remission ] ability complete 3day course without break experience intolerable side effect [ Tolerability ] .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Clindamycin</mesh_term>
	<mesh_term>Clindamycin palmitate</mesh_term>
	<mesh_term>Clindamycin phosphate</mesh_term>
	<criteria>Women symptoms vaginal discharge and/or odor clinical diagnosis vaginitis infective origin [ base symptom sign per speculum examination ] Age least 18 year Capable give write informed consent Agree intercourse 8 day day start treatment Agree douche use intravaginal product study period ( include tampon , medication device ) Postmenopausal woman Menstruating diagnosis Pregnancy Any antifungal antibiotic use 14 day prior enrolment Use oral intravaginal antibiotic within past 2 week Immunosuppressive drug within 4 month Presence vaginal / vulval ulcer Presence vulval , vaginal medical condition , include cervical neoplasia/ treatment might confound treatment response Inability keep return appointment History hypersensitivity clotrimazole , clindamycin lincomycin History regional enteritis , ulcerative colitis antibiotic associate colitis Significant disease acute illness Investigators assessment could complicate evaluation Intrauterine Device</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Clindamycin</keyword>
	<keyword>Clotrimazole</keyword>
	<keyword>Vaginal formulation</keyword>
	<keyword>Bacterial vaginosis</keyword>
	<keyword>Candidiasis</keyword>
	<keyword>Trichomoniasis</keyword>
	<keyword>Mixed vaginitis</keyword>
	<keyword>Infective vaginitis</keyword>
</DOC>